
Genes related to eye color may cause cancer of the eye.
Top news of the day from across the healthcare landscape.
Cancer genomics reveal genetic mutations that aid tumor growth in prostate cancer.
Treating cellular survival mechanism may prove to be a promising treatment approach for cancer.
New method able to reduce toxic side effects by avoiding use of chemotherapy.
Nanoparticle capsule to deliver experimental drug shows promise treating pancreatic cancer.
Etoposide may cause ovarian tissue damage that impacts the fertility of the unborn child.
Top news of the day from across the healthcare landscape.
Top news of the week in oncology, and cancer drug development.
Breast cancer patients who expected significant side effects from adjuvant hormone therapy reported worse adverse events.
A consensus about margins could reduce healthcare costs for patients with ductal carcinoma in-situ.
Researchers have discovered a mechanism that allows cancer cells to survive without nutrients.
Hormone receptor testing may be unnecessary in breast cancer patients.
Mechanism behind novel BRAF inhibitor resistance among patients with melanoma discovered.
Aromatase inhibitors in human estrogen-receptor positive breast cancer can cause tumor mutations.
Research identifies which melanoma patients will respond to immunotherapy drugs.
Pfizer and Medivation believe the merger could revolutionize cancer care.
Obesity becoming a growing health concern for cancer survivors, specifically breast and colorectal cancers.
Increased genetic knowledge about non-whites could lead to improved knowledge and treatments.
Protein inhibition shows promising reducing lung cancer progression.
Accumulation of chemicals found in drinking water supplied to 6 million people could lead to cancer and other health problems.
Identifying cancer cells’ metabolic states could improve treatments.
Caucasians found to have better skin cancer survival rates.
Top news of the day from across the health care landscape.
Top news of the week in oncology, and cancer drug development.
Blocking the migration path of cancer cells in the blood could create new, effective treatments for cancers, such as lymphoma.
Discovery may help tumor suppression on a molecular level.
Advance in lung cancer therapy achieved on molecular level.
Bacterial differences were seen between tissue from patients with and without breast cancer.